Hemispheric asymmetries of hypometabolism associated with semantic memory impairment in Alzheimer's disease: a study using positron emission tomography with fluorodeoxyglucose-F18

Semantic Memory ◽

Memory Impairment ◽

Fluorodeoxyglucose F18 ◽

Emission Tomography ◽

Hemispheric Asymmetries ◽

Hemispheric asymmetries of hypometabolism associated with semantic memory impairment in Alzheimer's disease: a study using positron emission tomography with fluorodeoxyglucose-F18

Psychiatry Research Neuroimaging ◽

10.1016/j.psychresns.2004.07.006 ◽

2004 ◽

Author(s):

R ZAHN ◽

F JUENGLING ◽

P BUBROWSKI ◽

E JOST ◽

P DYKIEREK ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Semantic Memory ◽

Memory Impairment ◽

Fluorodeoxyglucose F18 ◽

Emission Tomography ◽

Hemispheric Asymmetries ◽

Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18

Psychiatry Research Neuroimaging ◽

10.1016/j.pscychresns.2007.11.004 ◽

2008 ◽

Vol 164 (2) ◽

pp. 143-153 ◽

Cited By ~ 67

Author(s):

Igor Yakushev ◽

Christian Landvogt ◽

Hans-Georg Buchholz ◽

Andreas Fellgiebel ◽

Alexander Hammers ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Fluorodeoxyglucose F18 ◽

Emission Tomography ◽

Reference Area ◽

Neuronal Substrates for Semantic Memory: A Positron Emission Tomography Study in Alzheimer’s Disease

Dementia and Geriatric Cognitive Disorders ◽

10.1159/000051231 ◽

2000 ◽

Vol 12 (1) ◽

pp. 15-21 ◽

Cited By ~ 51

Author(s):

Nobutsugu Hirono ◽

Etsuro Mori ◽

Kazunari Ishii ◽

Toru Imamura ◽

Satoshi Tanimukai ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Semantic Memory ◽

Emission Tomography ◽

Positron Emission Tomography Study ◽

Positron Emission ◽

Neuronal Substrates

Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease

Yearbook of Neurology and Neurosurgery ◽

10.1016/s0513-5117(08)79054-9 ◽

2008 ◽

Vol 2008 ◽

pp. 7-8

Author(s):

T.J. Grabowski

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Fluorodeoxyglucose Positron Emission

Cognitive Reserve ◽

Emission Tomography ◽

Fluorodeoxyglucose Positron Emission Tomography ◽

Pittsburgh Compound B ◽

Positron Emission ◽

Tau Positron Emission Tomography (PET) Longitudinal Substudy Associated With: Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers in the Treatment of Autosomal-Dominant Alzheimer's Disease

Case Medical Research ◽

10.31525/ct1-nct03977584 ◽

2019 ◽

Author(s):

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Autosomal Dominant Alzheimer’S Disease

Autosomal Dominant ◽

Emission Tomography ◽

Mutation Carriers ◽

Positron Emission ◽

Significant effects of cholinesterase inhibitors on tau pathology in the Alzheimer's disease continuum: An in vivo positron emission tomography study

International Journal of Geriatric Psychiatry ◽

10.1002/gps.5522 ◽

2021 ◽

Author(s):

Fumihiko Yasuno ◽

Hiroyuki Minami

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Cholinesterase Inhibitors ◽

Emission Tomography ◽

Positron Emission Tomography Study ◽

Tau Pathology ◽

The risk prediction of Alzheimer’s disease based on the deep learning model of brain 18F-FDG positron emission tomography

Saudi Journal of Biological Sciences ◽

10.1016/j.sjbs.2019.12.004 ◽

2020 ◽

Vol 27 (2) ◽

pp. 659-665

Author(s):

Zhiguang Yang ◽

Zhaoyu Liu

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Deep Learning ◽

Risk Prediction ◽

Learning Model ◽

Emission Tomography ◽

Positron Emission ◽

18F Fdg ◽

Deep Learning Model

Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer's disease: A positron emission tomography study

Annals of Neurology ◽

10.1002/1531-8249(200008)48:2<194::aid-ana9>3.0.co;2-x ◽

2000 ◽

Vol 48 (2) ◽

pp. 194-200 ◽

Cited By ~ 99

Author(s):

Hitoshi Shinotoh ◽

Hiroki Namba ◽

Kiyoshi Fukushi ◽

Shin-Ichiro Nagatsuka ◽

Noriko Tanaka ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Cognitive Decline ◽

Acetylcholinesterase Activity ◽

Emission Tomography ◽

Positron Emission Tomography Study ◽

Progressive Loss ◽

FP43-TH-03 [18 F]BAY 94–9172 positron emission tomography in the detection/exclusion of cerebral amyloid beta: an open-label, multicentre study in patients with probable Alzheimer's disease compared with healthy volunteers

Journal of the Neurological Sciences ◽

10.1016/s0022-510x(09)70497-6 ◽

2009 ◽

Vol 285 ◽

pp. S126

Author(s):

H. Barthel ◽

H.J. Gertz ◽

S. Dresel ◽

I. Heuser ◽

P. Bartenstein ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Multicentre Study ◽

Healthy Volunteers ◽

Amyloid Beta ◽

Emission Tomography ◽

Open Label ◽

Positron Emission ◽

Cerebral Amyloid

Fluorodeoxyglucose positron emission tomography: emerging roles in the evaluation of putative Alzheimer's disease-modifying treatments

Neurobiology of Aging ◽

10.1016/j.neurobiolaging.2011.09.007 ◽

2011 ◽

Vol 32 ◽

pp. S44-S47 ◽

Cited By ~ 18

Author(s):

Eric M. Reiman

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Fluorodeoxyglucose Positron Emission

Emission Tomography ◽

Fluorodeoxyglucose Positron Emission Tomography ◽

Positron Emission ◽

Disease Modifying ◽